17-31528726-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032932.6(RAB11FIP4):c.1601A>G(p.Asn534Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,459,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032932.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RAB11FIP4 | NM_032932.6 | c.1601A>G | p.Asn534Ser | missense_variant | 13/15 | ENST00000621161.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RAB11FIP4 | ENST00000621161.5 | c.1601A>G | p.Asn534Ser | missense_variant | 13/15 | 1 | NM_032932.6 | P1 | |
RAB11FIP4 | ENST00000394744.6 | c.1295A>G | p.Asn432Ser | missense_variant | 11/13 | 2 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 exomes AF: 0.0000364 AC: 9AN: 247582Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134362
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1459742Hom.: 0 Cov.: 32 AF XY: 0.0000207 AC XY: 15AN XY: 726144
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2021 | The c.1601A>G (p.N534S) alteration is located in exon 13 (coding exon 13) of the RAB11FIP4 gene. This alteration results from a A to G substitution at nucleotide position 1601, causing the asparagine (N) at amino acid position 534 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at